Who owns emcure pharmaceuticals?
Namita Thapar is a popular Indian businesswoman who is the CEO of Emcure Pharmaceuticals her net worth is estimated at around 600 crores in 2021.
What does emcure pharmaceuticals make?
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. Emcure’s product portfolio includes tablets, capsules (both Softgel capsules and hard-gel capsules) and injectables.
Is emcure a generic company?
Emcure produces generic and biotechnology drugs. The company has six manufacturing facilities – five in Pune and one in Jammu.
Is Emcure pharma a good company?
Emcure is growing pharma company with good future projects and provides overall opportunities for both professional and personal development. Strong growth in generic business,oncology and domestic business is strong.
What is Emcure famous for?
Emcure has been ranked #1 in blood-related, gynaecology and HIV-related products consistently for the past three years.
Is Emcure Pharma a good company?
Is emcure pharmaceutical profitable?
In the fiscal 2021, the company reported profit at Rs 418.59 crore on the revenue of Rs 6091.80 crore. This compares with Rs 100.61 crore profit in FY20 and Rs 202.96 crore in FY19.
How much is Emcure worth?
Emcure Pharmaceuticals
| Parameters | Rs. Crore | % Change |
|---|---|---|
| Net Operating Income | 1,628.64 | 25.20 |
| Profit | 174.43 | 80.64 |
| Assets | 1,340.00 | 5.31 |
| Net Worth | 732.24 | 21.94 |
Is Satish Mehta a billionaire?
In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his US crown jewel, Heritage Pharmaceuticals, on a job well done.